Maryland § 13-3502
Full text of Maryland Maryland Code § 13-3502, with citation guidance and answers to common questions.
§ 13-3502.
(a) The Secretary shall establish guidelines for the co–prescribing of opioid overdose reversal drugs that are applicable to all licensed health care providers in the State who are authorized by law to prescribe a monitored prescription drug, as defined in § 21–2A–01 of this article.
(b) The guidelines established under subsection (a) of this section shall address the co–prescribing of opioid overdose reversal drugs for patients who are:
(1) At an elevated risk of overdose; and
(2) (i) Receiving opioid therapy for chronic pain;
(ii) Receiving a prescription for benzodiazepines; or
(iii) Being treated for opioid use disorders.
Frequently Asked Questions About Maryland § 13-3502
What does Maryland Code § 13-3502 cover?
Section 13-3502 is part of the Maryland Code, the codified statutory law of Maryland. It sets out the legal rule or procedure described in the text above. Statutes are amended regularly, so always verify against the official source.
How do I cite Maryland § 13-3502?
A common citation format is "Maryland Code § 13-3502" (Maryland). Legal writing may require the code abbreviation, section number, and year or edition. Match the style required by your court, professor, or publisher.
Is this the official text of Maryland law?
No. This page is for research and education and may not include the most recent amendments. For official current law, check the Maryland official source linked on this page or consult a licensed Maryland attorney.
How does Maryland § 13-3502 apply to my situation?
Statutes are interpreted in context, and application depends on your specific facts. Only a licensed attorney in Maryland can advise on how this section applies to you. Contact your state or local bar association for a referral.
Sources & Verification
Not legal advice. Verify against the official source and consult a licensed attorney in Maryland.